 |
|
 -Blocker Therapy of HypertensionAn Unfulfilled Promise
Alexander F. Khoury, MD;
Norman M. Kaplan, MD
JAMA. 1991;266(3):394-398.
Abstract
For various reasons, the  1-receptor blocker prazosin has been used infrequently as initial therapy for hypertension. The introduction of additional agents of this class with properties different from prazosin provides slower onset of action, which should reduce the degree of first-dose and postural hypotension and a longer duration of action, which allows for once-a-day dosage. A summary of the published data on efficacy, side effects, and special properties of this class of agents indicates that they will probably be used more extensively, particularly because of their ability to improve lipid and glucose-insulin metabolism.
(JAMA. 1991;266:394-398)
Author Affiliations
From the Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, Tex.
Footnotes
Reprint requests to University of Texas Southwestern Medical Center, Department of Internal Medicine, 5323 Harry Hines Blvd, Dallas, TX 75235-8899 (Dr Kaplan).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Effect of Antihypertensive Agents on the Development of Type 2 Diabetes Mellitus
Stump et al.
Mayo Clin Proc. 2006;81:796-806.
ABSTRACT
| FULL TEXT
Hypertension and the Vascular Patient
Samson
VASC ENDOVASCULAR SURG 2004;38:103-119.
ABSTRACT
Z-350, A Novel Compound with alpha 1-Adrenoceptor Antagonistic and Steroid 5alpha -Reductase Inhibitory Actions: Pharmacological Properties In Vivo
Fukuta et al.
J. Pharmacol. Exp. Ther. 1999;290:1013-1018.
ABSTRACT
| FULL TEXT
The Appropriate Goals of Antihypertensive Therapy: Neither Too Much Nor Too Little
Kaplan
ANN INTERN MED 1992;116:686-690.
ABSTRACT
|
